Related Experiment Video
Updated: Dec 22, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
MicroRNA-493-5p suppresses colorectal cancer progression via the PI3K-Akt-FoxO3a signaling pathway
1Department of Clinical Laboratory, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan, Jinshui District, Zhengzhou City, Henan, P.R. China. facaichn@163.com.
Objective:
MicroRNA493-5p (miR-493-5p) appears to have an essential role in the abnormal cell proliferation and migration observed in the development and progression of various cancers. However, the function and mechanism of action of miR-493-5p in colorectal cancer (CRC) is unclear.
Patients And Methods:
MiR-493-5p expression was analyzed in CRC patient tissue samples and cell lines by fluorescence quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). SW480 and Caco-2 cells were transfected with miR-493-5p mimics or treated with the phosphoinositide 3-kinase (PI3K) agonist 740Y-P. Cell proliferation was determined by colony formation and cell proliferation assays and cell migration and invasion by transwell migration and wound-healing assays. The Luciferase reporter assay was used to verify the association between the expression of miR-493-5p and PI3K activity. Expression levels of PI3K, protein kinase B(Akt), and forkhead box O 3a (FoxO3a) proteins were measured by Western blot analysis and immunofluorescence assay.
Results:
MiR-493-5p expression was significantly downregulated in CRC tissue samples and cell lines which was associated with progression of CRC. The proliferation, migration, and invasion of CRC cells were inhibited by miR-493-5p overexpression. The finding that miR-493-5p upregulation decreased PI3K, Akt, and FoxO3a protein expression revealed that it directly targets PI3K. Additionally, the miR-493-5p-mediated suppression of CRC cell proliferation, migration and invasion was counteracted by the PI3K agonist, indicating that miR-493-5p suppresses CRC progression by inhibiting the PI3K-Akt-FoxO3a signaling pathway.
Conclusions:
MiR-493-5p suppresses the proliferation, migration, invasion, and progression of CRC via the PI3K-Akt-FoxO3a signaling pathway.
Insights
MicroRNA493-5p (miR-493-5p) suppresses colorectal cancer (CRC) progression by inhibiting the PI3K-Akt-FoxO3a pathway. This microRNA is downregulated in CRC and its restoration reduces cancer cell proliferation, migration, and invasion.
Area of Science:
- Molecular Biology
- Oncology
- Gene Regulation
Background:
- MicroRNA493-5p (miR-493-5p) is implicated in cancer cell proliferation and migration.
- The specific role and mechanism of miR-493-5p in colorectal cancer (CRC) remain largely unelucidated.
Purpose of the Study:
- To investigate the function and mechanism of miR-493-5p in colorectal cancer (CRC) progression.
- To determine the molecular targets and signaling pathways regulated by miR-493-5p in CRC.
Main Methods:
- Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) for miR-493-5p expression analysis in CRC tissues and cell lines.
- Cell proliferation, migration, and invasion assays (colony formation, transwell, wound-healing) following miR-493-5p mimic transfection or PI3K agonist treatment.
- Luciferase reporter assays, Western blotting, and immunofluorescence to assess the miR-493-5p/PI3K interaction and downstream signaling (PI3K, Akt, FoxO3a).
Main Results:
- MiR-493-5p expression was significantly downregulated in CRC tissues and cell lines, correlating with disease progression.
- Overexpression of miR-493-5p inhibited CRC cell proliferation, migration, and invasion.
- MiR-493-5p directly targets PI3K, leading to decreased expression of PI3K, Akt, and FoxO3a proteins. PI3K agonist treatment counteracted the suppressive effects of miR-493-5p.
Conclusions:
- MiR-493-5p acts as a tumor suppressor in colorectal cancer.
- The miR-493-5p-mediated suppression of CRC progression occurs through inhibition of the PI3K-Akt-FoxO3a signaling pathway.
Related Concept Videos
MicroRNAs
MicroRNAs
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Experimental RNAi

